Heidelberg, Germany

Jorn Mockel

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorn Mockel. Retrieved from https://idiyas.com/inventor/jorn-mockel-teyzczdl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jorn Mockel: Innovator in Pharmaceutical Preparations

Introduction

Jorn Mockel is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on oral pharmaceutical preparations.

Latest Patents

Jorn Mockel holds a patent for an oral pharmaceutical preparation containing ibandronat. This invention showcases his expertise in developing effective medication formulations.

Career Highlights

Currently, Jorn Mockel is employed at Roche Diagnostics GmbH, a leading company in the healthcare sector. His role at Roche allows him to leverage his skills and knowledge in pharmaceutical development.

Collaborations

Throughout his career, Jorn has collaborated with esteemed colleagues such as Heinrich Woog and Rolf-Dieter Gabel. These partnerships have further enhanced his contributions to the field.

Conclusion

Jorn Mockel's work in pharmaceutical innovations, particularly his patent on ibandronat, highlights his valuable contributions to healthcare. His career at Roche Diagnostics GmbH and collaborations with other professionals underscore his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…